New Zealand markets closed

Voyageur Pharmaceuticals Ltd. (VM.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.07000.0000 (0.00%)
As of 09:59AM EDT. Market open.

Voyageur Pharmaceuticals Ltd.

4103B Center Street
Calgary, AB T2E 2Y6
Canada

https://voyageurpharmaceuticals.ca

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Brent Willis Bsc.EngPresident, CEO & Director131kN/A1971
Mr. Bradley Craig Willis P.Eng.Founder, COO & Director125.5kN/A1971
Mr. Albert DeslauriersChief Financial Officer32.4kN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

Corporate governance

Voyageur Pharmaceuticals Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.